FEZOLINETANT | FEZOLINETANT | ATC G02CX06
GENITO NEUROKININ 3 (NK3) RECEPTOR ANTAGONIST TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE | ORAL | Tmax 1.5 HOUR VD 189 LITER PPB 51 PERCENT Cl 10.8 LITER / HOUR HT 9.6 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER (0.29 MILLIGRAM PER MILLILITER) | NEUROKININ 3 (NK3) RECEPTOR | Neuromedin-K receptor UNIPROT P29371 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |